New Delhi [India], October 3 (ANI): German Ambassador to India, Walter J Lindner on Sunday asserted that his country would take the next step regarding Covaxin as soon as World Health Organization (WHO) would recognise Bharat Biotech's COVID vaccine to treat the virus.
New Delhi [India], October 2 (ANI): The decision on Bharat Biotech's Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in October, informed the top health experts in the country on Saturday.
Pune (Maharashtra) [India], October 1 (ANI): Serum Institute of India (SII) has supplied 78 crore doses of its COVID-19 vaccine Covishield so far and its target is to supply almost 21.50 crore doses in the month of October, informed the sources to ANI on Friday.
New Delhi [India], September 30 (ANI): India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.
New Delhi [India] September 30 (ANI): The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
New Delhi [India], September 28 (ANI): The emergency use authorisation (EUA) for Bharat Biotech's COVID-19 vaccine Covaxin has once again been delayed by the World Health Organisation, said sources.
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
New Delhi [India], September 17 (ANI): Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.
New Delhi [India], September 14 (ANI): The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday.
New Delhi [India], September 13 (ANI): The World Health Organisation's (WHO) approval for Bharat Biotech's COVID-19 vaccine, Covaxin, is expected this week, sources said on Monday.
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday.
Bharuch (Gujarat) [India], August 29 (ANI): Union Minister of Health and Family Welfare, Mansukh Mandaviya on Sunday launched the first commercial batch of Bharat Biotech's COVAXIN manufactured in Gujarat's Ankleshwar.